Home > Insider Trading > Filing (0001181431-11-004551)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1327111	Lynn Seely	C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-01-18	25,000	$3.60	41,666	No	4	M	Direct
Common Stock	Disposition	2011-01-18	25,000	$15.59	16,666	No	4	S	Direct
Common Stock	Acquisiton	2011-01-19	25,000	$3.60	41,666	No	4	M	Direct
Common Stock	Disposition	2011-01-19	25,000	$14.45	16,666	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2011-01-18	25,000	$0.00	25,000	$3.60
Common Stock	Stock Option (Right to Buy)	Disposition	2011-01-19	25,000	$0.00	25,000	$3.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
191,000		2015-03-14	No	4	M	Direct
166,000		2015-03-14	No	4	M	Direct

Footnotes

Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices between $15.19 and $16.01. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $14.29 and $14.57. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009.